Published Date: 02 Mar 2023
A review of more than 600,000 Finnish births from 2006 to 2016 found that mothers with type 1 diabetes had more than four times as many children born with heart defects.
Read Full NewsCOMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression
At a NeurologyLive Clinical Forum in Philadelphia, Pennsylvania, Chafic Karam, MD, chief of neuromuscular medicine at Penn Medicine, discussed treatment sequencing in myasthenia gravis.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 13, 2026.
As diabetes drugs are tested for repurposing in Alzheimer disease, the negative phase 3 EVOKE and EVOKE+ results for oral semaglutide have moved attention toward prevention and earlier, combination-based approaches.
Nick Cunniffe, MD, PhD, assistant professor and consultant neurologist at the University of Cambridge, discusses lessons from a decade of proof-of-concept remyelination trials in MS.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is National Epilepsy Awareness Month!
1.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
2.
Prostate cancer therapies: AI-based image analysis detects early organ damage
3.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
4.
Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?
5.
Alternative Medicine for Breast Cancer: Study Raises Concern
1.
Drug-Related Neutrophil Dysfunction: Mechanisms, Clinical Impact, and Management
2.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
3.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
4.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
5.
Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
Best Practices in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation